GL
EVH icon

GLG LLC’s Evolent Health EVH Stock Holding History

GLG LLC’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-47,764
Closed -$578K – 546
2015
Q4 		$578K Sell
47,764
-72,796
-60% -$1.07M 0.03% 418
2015
Q3 		$1.92M Sell
120,560
-142
-0.1% -$2.77K 0.05% 314
2015
Q2 		$2.35M Buy
+120,702
New +$2.25M 0.05% 334

Other funds holding EVH

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

GLG LLC's EVH Position: Q1 2016 in Review

GLG LLC sold out of Evolent Health (EVH) in Q1 2016, closing a stake of 47,764 shares — an estimated $578K sold.

GLG LLC first reported a position in EVH in Q2 2015 and held it in 3 quarters. The position peaked at $2.35M in Q2 2015. 70 funds tracked by Wall St. Rank hold EVH as of Q1 2016.

  • GLG LLC reported no remaining Evolent Health position as of Q1 2016 after selling out during the quarter.
  • GLG LLC sold 47,764 Evolent Health shares in Q1 2016, an estimated $578K.
  • GLG LLC first reported a position in Evolent Health in Q2 2015 and held it in 3 quarters.
  • GLG LLC's Evolent Health position peaked at $2.35M in Q2 2015.
  • 70 funds tracked by Wall St. Rank held Evolent Health as of Q1 2016.

Based on GLG LLC's 13F filing for Q1 2016, filed 16 May 2016.